Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BMS-641988
i
Other names:
BMS-641988
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
BMS
Drug class:
Androgen receptor antagonist
Related drugs:
‹
apalutamide (9)
nilutamide (4)
GT0918 (3)
bicalutamide implant (2)
EPI-7386 (2)
HC-1119 (1)
TAK 700 (1)
IONIS-AR-2.5Rx (0)
sulforafan alfadex (0)
TAS3681 (0)
TQB3720 (0)
TRC253 (0)
cyproterone acetate (0)
TOK-001 (0)
EPI-506 (0)
INO-464 (0)
apalutamide (9)
nilutamide (4)
GT0918 (3)
bicalutamide implant (2)
EPI-7386 (2)
HC-1119 (1)
TAK 700 (1)
IONIS-AR-2.5Rx (0)
sulforafan alfadex (0)
TAS3681 (0)
TQB3720 (0)
TRC253 (0)
cyproterone acetate (0)
TOK-001 (0)
EPI-506 (0)
INO-464 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
AR overexpression
Prostate Cancer
AR overexpression
Prostate Cancer
BMS-641988
Resistant: D – Preclinical
BMS-641988
Resistant
:
D
BMS-641988
Resistant: D – Preclinical
BMS-641988
Resistant
:
D
AR T877A
Prostate Cancer
AR T877A
Prostate Cancer
BMS-641988
Resistant: D – Preclinical
BMS-641988
Resistant
:
D
BMS-641988
Resistant: D – Preclinical
BMS-641988
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login